Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2698OMIM:149200Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome, also known as Bart-Pumphrey syndrome, is an extremely rare genetic disorder characterized by a distinctive combination of skin, nail, and hearing abnormalities. The condition affects multiple body systems including the integumentary system (skin and nails) and the auditory system. The four cardinal features are: knuckle pads (thickened skin over the finger joints), leukonychia (white discoloration of the nails), palmoplantar hyperkeratosis (thickening of the skin on the palms of the hands and soles of the feet), and sensorineural hearing loss, which can range from mild to profound and results from dysfunction of the inner ear or auditory nerve. The syndrome is caused by mutations in the GJB2 gene, which encodes connexin 26, a gap junction protein critical for cell-to-cell communication in the skin and inner ear. The knuckle pads typically appear during childhood and may become more prominent over time. Leukonychia is usually present from birth or early infancy. The degree of hearing impairment is variable among affected individuals, even within the same family. There is currently no cure for Bart-Pumphrey syndrome. Management is symptomatic and supportive. Hearing aids or cochlear implants may be recommended depending on the severity of hearing loss. Dermatological treatments such as keratolytic agents or emollients may help manage the skin thickening, though knuckle pads and palmoplantar keratoderma tend to be persistent. Regular audiological monitoring is important, particularly in childhood, to ensure appropriate hearing support and speech development.

Also known as:

Clinical phenotype terms— hover any for plain English:

LeukonychiaHP:0001820Congenital sensorineural hearing impairmentHP:0008527Knuckle padHP:0032541Mixed hearing impairmentHP:0000410Hyperkeratotic papuleHP:0045059
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome.

View clinical trials →

No actively recruiting trials found for Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome community →

No specialists are currently listed for Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndromeForum →

No community posts yet. Be the first to share your experience with Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome.

Start the conversation →

Latest news about Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome

No recent news articles for Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome

What is Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome?

Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome, also known as Bart-Pumphrey syndrome, is an extremely rare genetic disorder characterized by a distinctive combination of skin, nail, and hearing abnormalities. The condition affects multiple body systems including the integumentary system (skin and nails) and the auditory system. The four cardinal features are: knuckle pads (thickened skin over the finger joints), leukonychia (white discoloration of the nails), palmoplantar hyperkeratosis (thickening of the skin on the palms of the hands and soles of the fee

How is Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome inherited?

Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome typically begin?

Typical onset of Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome is childhood. Age of onset can vary across affected individuals.